| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA1270799
Max Phase: Preclinical
Molecular Formula: C29H41N5O3S
Molecular Weight: 539.75
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CCS(=O)(=O)N1CCC(C(CCN2C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C2)c2ccccc2)CC1
Standard InChI: InChI=1S/C29H41N5O3S/c1-4-38(36,37)34-14-10-24(11-15-34)27(23-8-6-5-7-9-23)12-13-32-16-25-18-33(19-26(25)17-32)29(35)28-21(2)30-20-31-22(28)3/h5-9,20,24-27H,4,10-19H2,1-3H3/t25-,26+,27?
Standard InChI Key: QKGLJRWKELQVMG-ZVBBVAIHSA-N
Associated Targets(Human)
C-C motif chemokine 5 54 Activities
Liver microsomes 16955 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Associated Targets(non-human)
Human immunodeficiency virus 3636 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 539.75 | Molecular Weight (Monoisotopic): 539.2930 | AlogP: 3.33 | #Rotatable Bonds: 8 |
| Polar Surface Area: 86.71 | Molecular Species: BASE | HBA: 6 | HBD: 0 |
| #RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: | CX Basic pKa: 9.86 | CX LogP: 1.13 | CX LogD: -1.29 |
| Aromatic Rings: 2 | Heavy Atoms: 38 | QED Weighted: 0.51 | Np Likeness Score: -1.13 |
References
| 1. Wanner J, Chen L, Lemoine RC, Kondru R, Jekle A, Heilek G, deRosier A, Ji C, Berry PW, Rotstein DM.. (2010) Evaluation of amide replacements in CCR5 antagonists as a means to increase intrinsic permeability. Part 2: SAR optimization and pharmacokinetic profile of a homologous azacyle series., 20 (22): [PMID:20855212] [10.1016/j.bmcl.2010.08.118] |
Source
Source(1):